|
GB0803932D0
|
|
Long term stabilisation of viruses and bacteriophage at high tempertures
|
|
GB0711149D0
|
|
Improvments to the stabilisation of active materials
|
|
GB0618294D0
|
|
An injector
|
|
GB0611327D0
|
|
Improvements to the stabilisation of active materials
|
|
GB0523638D0
|
|
Pharmaceutical device for the administration of substances to patients
|
|
GB0520129D0
|
|
Pharmaceutical compositions stabilized in glassy particles
|
|
GB0517688D0
|
|
Improvements in the stabilisation of biological materials
|
|
AU2005203369A1
|
|
Pharmaceutical liquid suspensions
|
|
JP2005314432A
|
|
Medicine liquid suspension
|
|
GB0509863D0
|
|
Apparatus for administrating substances into a body
|
|
GB0508655D0
|
|
Improvements relating to the administration of materials through the skin
|
|
AU2005232441A1
|
|
Liquids containing suspended glass particles
|
|
GB0417868D0
|
|
Pharmaceutical compositions stabilized in glassy particles
|
|
GB0414584D0
|
|
Improvements realting to the administration of materials through the skin
|
|
GB0408199D0
|
|
Liquids containing suspended sugar glass particles
|
|
JP2004196776A
|
|
Composition for stable injection liquid and method
|
|
ZA200302434B
|
|
Composition and method for stable injectable liquids.
|
|
US6808507B2
|
|
Safety injectors
|
|
US6623762B2
|
|
Composition and method for controlled release injections
|
|
NZ525026A
|
|
A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
|
